Health 2.0: How wellness and
the pharmaceutical industry
are transformed by connected
By Nitin Dahad
Health and wellness is a key area where technology can potentially innovate monitoring and diagnostics and delivery of treatment. But is the traditional health care industry, which includes the pharmaceutical companies, ready for it?
Not yet, says Aline Noizet, general manager of Health 2.0 in Barcelona. She explains, “Although pharma companies say that they have a holistic view of the patient, there are areas for improvement. For instance, every pharma company is running towards orphan drugs as it is more tractable than chronic diseases. Nonetheless, they need to understand the patients better, and place them more at the center of the processes. Both patients and payers are key groups for pharma companies.
The actual challenge is not so much to innovate but to define patients’ needs in a way that promotes smarter innovation. And this is one of the spots that definitely has room for collaboration between pharma and health tech companies.”
She says that pharmaceutical companies are starting to look at the health tech industry, especially connected objects, seeing them as a new market access point. “But many pharma companies are still in the ‘stand-by’ phase- they don’t have an innovation department that could actually embrace health tech. Their main concern towards connected objects remains compliance.” See the full article here.
This will be a key topic of discussion at the 6th annual Health 2.0 Conference in May 2015 in Barcelona, Spain. The conference will explore everything from gamification to help enhance wellness goals for patients, to integrating technology in tools for care in hospitals, how doctors access data and how they engage to treat patients. It will also look at the startups and investors playing in this space.